Clinical Trials Logo

Clinical Trial Summary

To compare between the effects of misoprostol with hyoscine N-butyl bromide and misoprostol alone on shortening the time of abortion induction in the second trimester.


Clinical Trial Description

The study will be conducted on 40 women who will undergo induction of abortion between 13-24 weeks with positive fetal pulsation. They will be randomly assigned to receive either only misoprostol 400 μg under the generic name of misotac tablets produced by Sigma company according to FIGO classification 2019 and a halved dose if the patient has a history of one or two cesarean sections, or misoprostol 400 μg plus intramuscular administration of hyoscine N-butyl bromide under the generic name of buscopan ampoule produced by Sanofi company. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06207539
Study type Interventional
Source Ain Shams Maternity Hospital
Contact
Status Completed
Phase Early Phase 1
Start date December 1, 2022
Completion date April 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT03220607 - Uterocervical Angle in the Termination of Second Trimester Pregnancy N/A
Completed NCT03134183 - 24-hour Mifepristone and Buccal Versus Mifepristone and Vaginal Misoprostol for Cervical Preparation for D&E Phase 4
Completed NCT04824118 - Clotting Parameters After Medical Abortion
Completed NCT00382538 - Mifepristone and Mid-Trimester Termination of Pregnancy N/A
Recruiting NCT03106389 - Misoprostol With And Without Transcervical Balloon Catheter In Second Trimester Termination Of Pregnancy Phase 4
Recruiting NCT05322252 - Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial Phase 4
Completed NCT05469594 - Second-trimester TOP : a Retrospective Study Comparing Complications at 12-14 vs 14-16 Weeks of Gestation
Completed NCT00495560 - A Pilot Study of Priming Before Induction Termination of Pregnancy N/A
Completed NCT05099991 - Transcervical Balloon Compared to Osmotic Dilators Prior to Surgical Abortion N/A